Acute Respiratory Distress Syndrome

Area of Science:

• Critical Care Medicine
• Pulmonology
• Pathophysiology

Background:

• Acute respiratory distress syndrome (ARDS) is a critical inflammatory lung condition characterized by increased alveolar permeability and high mortality.
• The Berlin definition provides a severity scale for ARDS based on the arterial oxygen partial pressure to fraction of inspired oxygen (PaO2/FIO2) ratio.

Purpose of the Study:

• To review the current understanding and therapeutic strategies for Acute Respiratory Distress Syndrome (ARDS).
• To highlight the established and emerging treatments for ARDS management.

Main Methods:

• Review of existing literature and clinical trial data, including the ARDSnet trials.
• Analysis of therapeutic interventions such as low tidal volume ventilation, extracorporeal membrane oxygenation (ECMO), prone positioning, and positive end-expiratory pressure (PEEP).

Main Results:

• Low tidal volume ventilation (6-8 mL/kg ideal body weight) is a cornerstone therapy proven to decrease ARDS mortality.
• Prone positioning improves oxygenation, while ECMO is used for severe refractory hypoxemia.
• PEEP with lung recruitment maneuvers also demonstrates clinical benefit.

Conclusions:

• Low tidal volume ventilation remains the most effective strategy for reducing ARDS mortality.
• Emerging therapies like vasodilators and neuromuscular agents require further investigation to establish their role in ARDS treatment.
• A multi-faceted approach combining established and novel therapies is crucial for optimizing ARDS patient outcomes.